Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinto, J. T.
Right arrow Articles by Heston, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinto, J. T.
Right arrow Articles by Heston, W. D.

Clinical Cancer Research, Vol 2, Issue 9 1445-1451, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells

JT Pinto, BP Suffoletto, TM Berzin, CH Qiao, S Lin, WP Tong, F May, B Mukherjee and WD Heston
Nutrition Research Laboratory, Urology Research Laboratory, Pharmacology Analytical Laboratory, and George M. O'Brien Urology Research Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

A novel monoclonal antibody has been developed that reacts strongly with human prostatic cancer, especially tumors of high grade. This antibody (7E11C-5) is currently in Phase 3 trials as an imaging agent for metastatic disease. We have cloned the gene that encodes the antigen that is recognized by the 7E11C-5 monoclonal antibody and have designated this unique protein prostate-specific membrane (PSM) antigen. PSM antigen is a putative class II transmembranous glycoprotein exhibiting a molecular size of Mr 94,000. Functionally, class II membrane proteins serve as transport or binding proteins or have hydrolytic activity. Preliminary studies have demonstrated binding of pteroylmonoglutamate (folate) to membrane fractions that also cross-reacted with the PSM monoclonal antibody. We observed substantial carboxypeptidase activity as folate hydrolase associated with PSM antigen. The purpose of our study was to demonstrate that human prostatic carcinoma cells expressing PSM antigen exhibit folate hydrolase activity using methotrexate triglutamate (MTXGlu3) and pteroylpentaglutamate (PteGlu5) as substrates. Isolated membrane fractions from four human prostate cancer cell lines (LNCaP, PC-3, TSU-Prl, and Duke-145) were examined for folate hydrolase activity using capillary electrophoresis. After timed incubations at various pH ranges and in the presence and absence of thiol reagents, separation of pteroyl(glutamate)n derivatives was achieved with an electrolyte of sodium borate and SDS, while absorbance was monitored at 300 nm. The results demonstrate clearly that LNCaP cells, which highly express PSM, hydrolyze gamma-glutamyl linkages of MTXGlu3. The membrane-bound enzyme is an exopeptidase, because it progressively liberates glutamates from MTXGlu3 and PteGlu5 with accumulation of MTX and PteGlu1, respectively. The semipurified enzyme has a broad activity from pH 2.5 to 9.5 and exhibits activity maxima at pH 5 and 8. Enzymatic activity is maintained in the presence of reduced glutathione, homocysteine, and p-hydroxymercuribenzoate (0.05-0.5 mm) but was inhibited weakly by DTT (>/=0.2 mm). By contrast to LNCaP cell membranes, membranes isolated from other human prostate adenocarcinoma cells (PC-3, Duke-145, and TSU-Pr1) did not exhibit comparable hydrolase activity, nor did they react with 7E11-C5 monoclonal antibody. After transfection of PC-3 cells with a full-length 2.65-kb PSM cDNA subcloned into a pREP7 eukaryotic expression vector, non-PSM antigen-expressing PC-3 cells developed immunoreactivity to 7E11-C5 monoclonal antibody and demonstrated folate hydrolase activities and optimum pH activity profiles identical to those of LNCaP cells. The membrane-bound enzymes from both LNCaP- and PC-3-transfected cells also have a capacity to hydrolyze an alpha-linked glutamyl moiety from N-acetyl-alpha-aspartylglutamate. We have identified that PSM antigen is a pteroyl poly-gamma-glutamyl carboxypeptidase (folate hydrolase) and is expressed strongly in human prostate cancer. Cancer cells that express this enzyme are resistant to methotrexate therapy. Those developing future therapeutic strategies in the treatment of prostate cancer that utilize folate antagonists need to consider this mechanism of resistance.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. Mhawech-Fauceglia, D. J. Smiraglia, W. Bshara, C. Andrews, J. Schwaller, S. South, D. Higgs, S. Lele, F. Herrmann, and K. Odunsi
Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 571 - 577.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. J. Durso, S. Andjelic, J. P. Gardner, D. J. Margitich, G. P. Donovan, R. R. Arrigale, X. Wang, M. F. Maughan, T. L. Talarico, R. A. Olmsted, et al.
A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses
Clin. Cancer Res., July 1, 2007; 13(13): 3999 - 4008.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Aggarwal, P. Singh, O. Topaloglu, J. T. Isaacs, and S. R. Denmeade
A dimeric Peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.
Cancer Res., September 15, 2006; 66(18): 9171 - 9177.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. E. Conway, N. Petrovic, Z. Li, W. Heston, D. Wu, and L. H. Shapiro
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.
Mol. Cell. Biol., July 1, 2006; 26(14): 5310 - 5324.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. K. Rajasekaran, G. Anilkumar, and J. J. Christiansen
Is prostate-specific membrane antigen a multifunctional protein?
Am J Physiol Cell Physiol, May 1, 2005; 288(5): C975 - C981.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. I. Davis, M. J. Bennett, L. M. Thomas, and P. J. Bjorkman
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
PNAS, April 26, 2005; 102(17): 5981 - 5986.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
H. Zeng, Q. Wu, H. Li, Q. Wei, Y. Lu, X. Li, F. Wang, F. Zhao, Z. Ding, and Y. Yang
Construction of Prostate-Specific Expressed Recombinant Plasmids With High Transcriptional Activity of Prostate-Specific Membrane Antigen (PSMA) Promoter/Enhancer
J Androl, March 1, 2005; 26(2): 215 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Ghosh, X. Wang, E. Klein, and W. D.W. Heston
Novel Role of Prostate-Specific Membrane Antigen in Suppressing Prostate Cancer Invasiveness
Cancer Res., February 1, 2005; 65(3): 727 - 731.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. I. Milowsky, D. M. Nanus, L. Kostakoglu, S. Vallabhajosula, S. J. Goldsmith, and N. H. Bander
Phase I Trial of Yttrium-90--Labeled Anti--Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer
J. Clin. Oncol., July 1, 2004; 22(13): 2522 - 2531.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. V. Tricoli, M. Schoenfeldt, and B. A. Conley
Detection of Prostate Cancer and Predicting Progression: Current and Future Diagnostic Markers
Clin. Cancer Res., June 15, 2004; 10(12): 3943 - 3953.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
S. A. Rajasekaran, G. Anilkumar, E. Oshima, J. U. Bowie, H. Liu, W. Heston, N. H. Bander, and A. K. Rajasekaran
A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen
Mol. Biol. Cell, December 1, 2003; 14(12): 4835 - 4845.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Schulke, O. A. Varlamova, G. P. Donovan, D. Ma, J. P Gardner, D. M. Morrissey, R. R. Arrigale, C. Zhan, A. J. Chodera, K. G. Surowitz, et al.
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
PNAS, October 28, 2003; 100(22): 12590 - 12595.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Anilkumar, S. A. Rajasekaran, S. Wang, O. Hankinson, N. H. Bander, and A. K. Rajasekaran
Prostate-specific Membrane Antigen Association with Filamin A Modulates Its Internalization and NAALADase Activity
Cancer Res., May 15, 2003; 63(10): 2645 - 2648.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. W. Smith, Z. N. Yue, G. K. Geiss, N. Y. Sadovnikova, V. S. Carter, L. Boix, C. A. Lazaro, G. B. Rosenberg, R. E. Bumgarner, N. Fausto, et al.
Identification of Novel Tumor Markers in Hepatitis C Virus-associated Hepatocellular Carcinoma
Cancer Res., February 15, 2003; 63(4): 859 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Warren, L. Li, W. Song, E. Holle, Y. Wei, T. Wagner, and X. Yu
In Vitro Targeted Killing of Prostate Tumor Cells by a Synthetic Amoebapore Helix 3 Peptide Modified with Two {gamma}-linked Glutamate Residues at the COOH Terminus
Cancer Res., September 1, 2001; 61(18): 6783 - 6787.
[Abstract] [Full Text] [PDF]

Home page
 Plant CellHome page
C. A. Helliwell, A. N. Chin-Atkins, I. W. Wilson, R. Chapple, E. S. Dennis, and A. Chaudhury
The Arabidopsis AMP1 Gene Encodes a Putative Glutamate Carboxypeptidase
PLANT CELL, September 1, 2001; 13(9): 2115 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. T. Pinto and R. S. Rivlin
Antiproliferative Effects of Allium Derivatives from Garlic
J. Nutr., March 1, 2001; 131(3): 1058S - 1060.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
A. M. Devlin, E.-h. Ling, J. M. Peerson, S. Fernando, R. Clarke, A. D. Smith, and C. H. Halsted
Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia
Hum. Mol. Genet., November 1, 2000; 9(19): 2837 - 2844.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-L. Gala, S. Loric, Y. Guiot, S. R. Denmeade, A. Gady, F. Brasseur, M. Heusterspreute, P. Eschwège, Philippe De Nayer, P. Van Cangh, et al.
Expression of Prostate-specific Membrane Antigen in Transitional Cell Carcinoma of the Bladder: Prognostic Value?
Clin. Cancer Res., October 1, 2000; 6(10): 4049 - 4054.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
S. S. Chang, D. S. O'Keefe, D. J. Bacich, V. E. Reuter, W. D. W. Heston, and P. B. Gaudin
Prostate-specific Membrane Antigen Is Produced in Tumor-associated Neovasculature
Clin. Cancer Res., October 1, 1999; 5(10): 2674 - 2681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. S. Chang, V. E. Reuter, W. D. W. Heston, N. H. Bander, L. S. Grauer, and P. B. Gaudin
Five Different Anti-Prostate-specific Membrane Antigen (PSMA) Antibodies Confirm PSMA Expression in Tumor-associated Neovasculature
Cancer Res., July 1, 1999; 59(13): 3192 - 3198.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Gingras, C. Richard, M. El-Alfy, C. R. Morales, M. Potier, and A. V. Pshezhetsky
Purification, cDNA Cloning, and Expression of a New Human Blood Plasma Glutamate Carboxypeptidase Homologous to N-Acetyl-aspartyl-{alpha}-glutamate Carboxypeptidase/Prostate-specific Membrane Antigen
J. Biol. Chem., April 23, 1999; 274(17): 11742 - 11750.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. N. Pangalos, J.-M. Neefs, M. Somers, P. Verhasselt, M. Bekkers, L. van der Helm, E. Fraiponts, D. Ashton, and R. D. Gordon
Isolation and Expression of Novel Human Glutamate Carboxypeptidases with N-Acetylated alpha -Linked Acidic Dipeptidase and Dipeptidyl Peptidase IV Activity
J. Biol. Chem., March 26, 1999; 274(13): 8470 - 8483.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. S. Speno, R. Luthi-Carter, W. L. Macias, S. L. Valentine, A. R. T. Joshi, and J. T. Coyle
Site-Directed Mutagenesis of Predicted Active Site Residues in Glutamate Carboxypeptidase II
Mol. Pharmacol., January 1, 1999; 55(1): 179 - 185.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. H. Halsted, E.-h. Ling, R. Luthi-Carter, J. A. Villanueva, J. M. Gardner, and J. T. Coyle
Folylpoly-gamma -glutamate Carboxypeptidase from Pig Jejunum. MOLECULAR CHARACTERIZATION AND RELATION TO GLUTAMATE CARBOXYPEPTIDASE II
J. Biol. Chem., August 7, 1998; 273(32): 20417 - 20424.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Luthi-Carter, A. K. Barczak, H. Speno, and J. T. Coyle
Molecular Characterization of Human Brain N-Acetylated alpha -Linked Acidic Dipeptidase (NAALADase)
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1020 - 1025.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
M. S. Rhee, B. Lindau-Shepard, K. J. Chave, J. Galivan, and T. J. Ryan
Characterization of Human Cellular gamma -Glutamyl Hydrolase
Mol. Pharmacol., June 1, 1998; 53(6): 1040 - 1046.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Luthi-Carter, U. V. Berger, A. K. Barczak, M. Enna, and J. T. Coyle
Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II
PNAS, March 17, 1998; 95(6): 3215 - 3220.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. L. Shneider, S. Thevananther, M. S. Moyer, H. C. Walters, P. Rinaldo, P. Devarajan, A. Q. Sun, P. A. Dawson, and M. Ananthanarayanan
Cloning and Characterization of a Novel Peptidase from Rat and Human Ileum
J. Biol. Chem., December 5, 1997; 272(49): 31006 - 31015.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.